Allarity Therapeutics, Inc. (ALLR)
0.96
-0.02
(-1.63%)
USD |
NASDAQ |
Nov 06, 10:20
Allarity Therapeutics EPS Diluted (Quarterly) : -0.214 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.214 |
| March 31, 2026 | -0.1722 |
| December 31, 2025 | -0.2098 |
| September 30, 2025 | -0.1904 |
| June 30, 2025 | -0.1493 |
| March 31, 2025 | -0.2451 |
| December 31, 2024 | -1.021 |
| September 30, 2024 | -7.712 |
| June 30, 2024 | -3.405 |
| March 31, 2024 | -20905.51 |
| December 31, 2023 | -175.51 |
| September 30, 2023 | -1346.09 |
| Date | Value |
|---|---|
| June 30, 2023 | -15766.33 |
| March 31, 2023 | -106238.4 |
| December 31, 2022 | -192763.2 |
| September 30, 2022 | -568688.4 |
| June 30, 2022 | -603674.4 |
| March 31, 2022 | -471466.8 |
| December 31, 2021 | -1.745M |
| September 30, 2021 | -146370.0 |
| June 30, 2021 | -559860.0 |
| March 31, 2021 | -205363.2 |
| September 30, 2020 | -4326.00 |
| June 30, 2020 | -11659.20 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.405M |
| Total Expenses (Quarterly) | 3.405M |
| Enterprise Value | 10.83M |
| Earnings Yield | -81.92% |
| Normalized Earnings Yield | -81.32 |